AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018
Jun 15, 2018
30583_dirs_2018-06-14_37dd7274-0669-4ff8-9457-4403bf33435f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-06-05
Reporting Person: HOMBACH ROBERT J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-05 | Common Stock | A | 4300 | — | Acquired | 7480 | Direct |
Footnotes
F1: This transaction, originally due to be reported on Thursday, June 7, 2018, is being reported late due to an administrative oversight.
F2: Restricted stock units granted on June 5, 2018. Price not applicable.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19